Anonglack Vongpachith

George Washington University

Papers

1

Total Citations

2

H-Index

1

About

Dr. Anonglack Vongpachith is a dedicated clinician-researcher whose work centers on refining treatment paradigms for head and neck cancers, particularly locally advanced oropharyngeal squamous cell carcinoma (OPSCC). Her major contribution lies in pioneering de-escalation strategies that aim to reduce the lifelong morbidity associated with standard chemoradiation. Her pivotal Phase II study investigated a novel approach combining induction chemotherapy with transoral robotic surgery (TORS) as definitive treatment, offering a promising alternative to spare patients from the toxicities of radiation. This work, which has garnered citations and informed subsequent retrospective analyses, reflects a commitment to improving both oncologic outcomes and quality of life. Dr. Vongpachith’s research is notable for its patient-centered focus, challenging conventional protocols to prioritize functional preservation without compromising survival. Her findings continue to influence surgical oncology and head and neck cancer management, marking her as a thoughtful innovator in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Phase II study: Induction chemotherapy and transoral surgery as definitive treatment (Tx) for locally advanced oropharyngeal squamous cell carcinoma (OPSCC)—An update and retrospective review of non-study patients.
2 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: George Washington University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago